IGF-1 LR3 (1 mg)

IGF-1 LR3 is a modified analogue of Insulin-Like Growth Factor-1 (IGF-1), engineered with amino-acid substitutions that extend its stability and binding characteristics in research environments. Compared to native IGF-1, the LR3 variant demonstrates reduced affinity for IGF binding proteins, allowing for prolonged interaction with target receptors in experimental settings.

In laboratory research, IGF-1 LR3 has been studied for its involvement in cell growth signaling, protein synthesis pathways, and cellular differentiation mechanisms. Its extended activity profile has made it a commonly referenced compound in studies examining growth-related, metabolic, and regenerative signaling pathways.

Ongoing research continues to explore its receptor dynamics, molecular behavior, and downstream signaling effects under controlled laboratory conditions.